Header Logo

Connection

Eliza Chakravarty to Scleroderma, Diffuse

Back to Details
This is a "connection" page, showing publications Eliza Chakravarty has written about Scleroderma, Diffuse.
Eliza Chakravarty
Connection Strength
0.507
Scleroderma, Diffuse
  1. Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. Arthritis Res Ther. 2015 Jun 13; 17:159.
    View in: PubMed
    Score: 0.507
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.